Kineret (Anakinra 100 mg / 0.67 mL solution) is an interleukin-1 receptor antagonist used for: 

Rheumatoid Arthritis (RA): Reduction in signs and symptoms and resisting the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients aged 18 years or older who have failed single/multiple disease modifying antirheumatic drugs (DMARDs). 

Cryopyrin-Associated Periodic Syndromes (CAPS): Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). 

Kineret (Anakinra) is an FDA approved drug.

• Do not use kineret 100 mg in patients with known hypersensitivity to E coli-derived proteins, Kineret, or any other components of the product. 
• Administration of Kineret injection in combination with TNF blocking agents is not recommended. 
• Neutrophil counts should be assessed before initiating therapy with anakinra injection, and while on therapy, monthly for three months, and thereafter quarterly for a period up to one year.
• Treatment with anakinra drug should not be initiated in those patients who are with active infections. 

What documents are required to import KINERET to India?

KINERET Injection (Anakinra 100 mg/0.67 mL solution) can be imported by patients or government hospitals on the name of the patients only. 

The following documentation required to import the product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients id proof (issued by government of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is KINERET available in India?

KINERET is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Genuine and reliable source from Canada, Europe, USA and Australia
• Ensuring 100% transparency.

KINERET can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India. 

Indian Pharma Network can facilitate the supply of KINERET (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91 965087751- Toll Free  – 18008891064 for kineret price in India. 

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the Kineret Injection (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

Indian Pharma Network helps you to connect with potential distributors, wholesalers, suppliers and dealers of Kineret in India. 

What is the Generic Name for the trade name drug Kineret® ?

Anakinra is Generic Name for the trade name drug Kineret®.

What is the Manufacturer Name of Kineret®?

Kineret® is manufactured by Swedish Orphan Biovitrum AB. 

When and by whom Kineret is approved?

Kineret was approved by the FDA in 2001.

What is the dosage and form of Kineret® available?

Kineret® is available as a 100 mg/0.67 mL solution for Subcutaneous Injection. 

What are the most commonly reported side effects of Kineret®? 

The most commonly reported kineret side effects (incidence ≥ 5%) when used for Rheumatoid Arthritis (RA) are injection site reaction, upper respiratory tract infection, worsening of rheumatoid arthritis, headache, diarrhea, nausea, sinusitis, arthralgia, abdominal pain and flu like-symptoms. 

The most commonly reported anakinra side effects in the first 6 months of treatment (incidence >10%) when used for Cryopyrin Associated Periodic Syndromes (CAPS) are headache, vomiting, injection site reaction, arthralgia, nasopharyngitis and pyrexia. 

What are the Highlights of prescribing information for Kineret®?

Click Here to download full Kineret prescribing information.